Le produit a bien été ajouté au panier.

discount label
H-ANYKFTLV-OH
Vue en 3D

Biosynth logo

H-ANYKFTLV-OH

Ref. 3D-PP43664

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Livraison estimée en/au États-Unis, le vendredi 27 décembre 2024

Informations sur le produit

Nom :
H-ANYKFTLV-OH
Synonymes :
  • NH2-Ala-Asn-Tyr-Lys-Phe-Thr-Leu-Val-OH
Description :

Peptide H-ANYKFTLV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ANYKFTLV-OH include the following: Trypanosoma cruzi infection from the view of CD8+ T cell immunity-an infection model for developing T cell vaccine Y Miyahira - Parasitology International, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1383576907001006 Immunization with lipopolysaccharide-activated dendritic cells generates a specific CD8+ T cell response that confers partial protection against infection with L Biscari, CD Kaufman, C Farre, V Huhn - Frontiers in Cellular , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fcimb.2022.897133/full Endogenous CD4+ CD25+ Regulatory T Cells Have a Limited Role in the Control of Trypanosoma cruzi Infection in Mice J Kotner, R Tarleton - Infection and immunity, 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.01500-06 The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the J Ersching, JR Vasconcelos , CP Ferreira - PLoS , 2016 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005593 A Human Trypanosome Suppresses CD8+ T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4+ Foxp3+ T Cells J Ersching, AS Basso , VLG Kalich, KR Bortoluci - PLoS , 2016 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005698 Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruziinfection J Bustamante , R Tarleton - Memorias do Instituto Oswaldo Cruz, 2015 - SciELO Brasilhttps://www.scielo.br/j/mioc/a/9fZbSqSK7vgyGv7nzjvYJQp/?stop=next&lang=en&format=html Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance F Tzelepis, BCG de Alencar , MLO Penido - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/180/3/1737/75779 Trypanosoma cruzi causes paralyzing systemic necrotizing vasculitis driven by pathogen-specific type I immunity in mice E Roffacaª , APMP Marino, J Weaver, W Wan - Infection and , 2016 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.01497-15 Generation of Trypanosoma cruzi-Specific CD8+ T-Cell Immunity Is Unaffected by the Absence of Type I Interferon Signaling DL Martin, K Murali-Krishna, RL Tarleton - Infection and immunity, 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.00275-10 CpG and Interleukin-15 Synergize to Enhance IFN-γ Production by Activated CD8+ T Cells D Cobb, S Guo , RB Smeltz - BioMed research international, 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2013/924023 Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells CS Rosenberg, W Zhang, JM Bustamante - Infection and , 2016 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.00241-16 CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance CS Rosenberg, DL Martin - The Journal of Immunology, 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/185/1/560/82952 CD8+ T cells in Trypanosoma cruzi infection AM Padilla, JM Bustamante , RL Tarleton - Current opinion in immunology, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0952791509001393 Cutting edge: augmenting muscle MHC expression enhances systemic pathogen control at the expense of T cell exhaustion AD Pack, RL Tarleton - The Journal of Immunology, 2020 - journals.aai.orghttps://journals.aai.org/jimmunol/article/205/3/573/60735 Highly competent, non-exhausted CD8+ T cells continue to tightly control pathogen load throughout chronic Trypanosoma cruzi infection AD Pack, MH Collins , CS Rosenberg - PLoS , 2018 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1007410 Functional CD8+ T cells mediate parasite control throughout experimental Trypanosoma cruzi infection AD Pack - 2016 - getd.libs.uga.eduhttp://getd.libs.uga.edu/pdfs/pack_angela_d_201612_phd.pdf Trypanosoma cruzi Binds to Cytokeratin through Conserved Peptide Motifs Found in the Laminin-G-Like Domain of the gp85/Trans-sialidase Proteins AAR Teixeira , VCS de Vasconcelos - PLoS neglected , 2015 - journals.plos.orghttps://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0004099

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP43664 H-ANYKFTLV-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".